8-109087635-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_003301.7(TRHR):āc.123A>Gā(p.Val41=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00352 in 1,614,168 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0022 ( 2 hom., cov: 32)
Exomes š: 0.0037 ( 9 hom. )
Consequence
TRHR
NM_003301.7 synonymous
NM_003301.7 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.459
Genes affected
TRHR (HGNC:12299): (thyrotropin releasing hormone receptor) This gene encodes a G protein-coupled receptor for thyrotropin-releasing hormone (TRH). Upon binding to TRH, this receptor activates the inositol phospholipid-calcium-protein kinase C transduction pathway. Mutations in this gene have been associated with generalized thyrotropin-releasing hormone resistance. [provided by RefSeq, Sep 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 8-109087635-A-G is Benign according to our data. Variant chr8-109087635-A-G is described in ClinVar as [Benign]. Clinvar id is 715012.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-109087635-A-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.459 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRHR | NM_003301.7 | c.123A>G | p.Val41= | synonymous_variant | 2/3 | ENST00000518632.2 | NP_003292.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRHR | ENST00000518632.2 | c.123A>G | p.Val41= | synonymous_variant | 2/3 | 5 | NM_003301.7 | ENSP00000430711 | P1 | |
TRHR | ENST00000311762.2 | c.123A>G | p.Val41= | synonymous_variant | 1/2 | 1 | ENSP00000309818 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00217 AC: 330AN: 152164Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
330
AN:
152164
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00209 AC: 526AN: 251386Hom.: 2 AF XY: 0.00216 AC XY: 294AN XY: 135868
GnomAD3 exomes
AF:
AC:
526
AN:
251386
Hom.:
AF XY:
AC XY:
294
AN XY:
135868
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00366 AC: 5352AN: 1461886Hom.: 9 Cov.: 31 AF XY: 0.00352 AC XY: 2562AN XY: 727242
GnomAD4 exome
AF:
AC:
5352
AN:
1461886
Hom.:
Cov.:
31
AF XY:
AC XY:
2562
AN XY:
727242
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00217 AC: 330AN: 152282Hom.: 2 Cov.: 32 AF XY: 0.00212 AC XY: 158AN XY: 74462
GnomAD4 genome
AF:
AC:
330
AN:
152282
Hom.:
Cov.:
32
AF XY:
AC XY:
158
AN XY:
74462
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
TRHR-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 22, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at